Most Read Articles
06 Jul 2020
Routinely used for treating cardiovascular diseases, statins have been shown to benefit other conditions, and new evidence suggests that using the drug at high intensity reduces the risk of hip or knee replacement, an effect that may be specific to rheumatoid arthritis.
Jairia Dela Cruz, 06 Jul 2020
Following vegan and vegetarian diets, which offer plenty of what is good for health, has been reported to have a downside: an increased risk of depression and anxiety, especially for younger adults.
Pearl Toh, 29 Jun 2020
Having migraine during midlife appears to be associated with a higher risk of developing dementia in later life, according to a large population-based longitudinal Danish study presented at the AHS* 2020 Virtual Meeting, indicating that migraine may be a risk factor for dementia.
Roshini Claire Anthony, 5 days ago

Upadacitinib may be a suitable treatment for patients with active psoriatic arthritis (PsA) who have insufficient response to non-biologic disease-modifying anti-rheumatic drugs (non-bDMARDs), according to results of the phase III SELECT-PsA-1* trial presented at EULAR 2020.

Serodiscordant condomless anal intercourse common among young men living with HIV

03 Jun 2020

Condomless anal intercourse (CAI), even among serodiscordant (SD-CAI) participants, is common among young, gay, bisexual, and other men who have sex with men (YGBMSM) living with HIV with detectable viral loads, a recent study has shown.

The study included 146 YGBMSM (aged 16–24 years) with detectable HIV viral loads. Sexual risk and behaviours were assessed through interviews, and mental health was evaluated using tools such as the 20-item Centre for Epidemiologic Studies Depression and the Generalized Anxiety Disorder scales. Substance use, social media use, stigma, and beliefs about the transmission of HIV were all also considered as factors.

Participants reported having a median of 1.0 male intercourse partners over the last 3 months. More than half (52.2 percent) noted that they engaged in any type of CAI, of whom 90.0 percent reported receptive CAI.

Notably, 57.1 percent of those who reported any CAI noted that their partner was either HIV negative or had an unknown status.

Relationship status emerged as the strongest predictor for CAI, such that those in a committed partnership were significantly more likely to engage in unprotected intercourse. The risk of CAI was also stronger among those with substance use habits and those who looked for sex online.

The same correlates were found to be important predictors of SD-CAI. This was especially true among those with problematic substance use habits and those who searched for sex partners online daily. Stronger perceptions of a rise in homophobia and a greater degree of internalized homophobia were also important determinants of engaging in SD-CAI.

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Doctor - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
06 Jul 2020
Routinely used for treating cardiovascular diseases, statins have been shown to benefit other conditions, and new evidence suggests that using the drug at high intensity reduces the risk of hip or knee replacement, an effect that may be specific to rheumatoid arthritis.
Jairia Dela Cruz, 06 Jul 2020
Following vegan and vegetarian diets, which offer plenty of what is good for health, has been reported to have a downside: an increased risk of depression and anxiety, especially for younger adults.
Pearl Toh, 29 Jun 2020
Having migraine during midlife appears to be associated with a higher risk of developing dementia in later life, according to a large population-based longitudinal Danish study presented at the AHS* 2020 Virtual Meeting, indicating that migraine may be a risk factor for dementia.
Roshini Claire Anthony, 5 days ago

Upadacitinib may be a suitable treatment for patients with active psoriatic arthritis (PsA) who have insufficient response to non-biologic disease-modifying anti-rheumatic drugs (non-bDMARDs), according to results of the phase III SELECT-PsA-1* trial presented at EULAR 2020.